Suppression of Chromosome Healing and Anticheckpoint Pathways in Yeast Postsenescence Survivors

Tekijä Lai, Xianning, Heierhorst, Jörg
Julkaistu 2013

Molecular Basis for Lysine Specificity in the Yeast Ubiquitin-Conjugating Enzyme Cdc34

Tekijä Sadowski, Martin, Suryadinata, Randy, Lai, Xianning, Heierhorst, Jörg, Sarcevic, Boris
Julkaistu 2010

Yeast hEST1A/B (SMG5/6)–Like Proteins Contribute to Environment-Sensing Adaptive Gene Expression Responses

Tekijä Lai, Xianning, Beilharz, Traude, Au, Wei-Chun, Hammet, Andrew, Preiss, Thomas, Basrai, Munira A., Heierhorst, Jörg
Julkaistu 2013

MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells

Tekijä Lai, Xianning, Broderick, Ronan, Bergoglio, Valérie, Zimmer, Jutta, Badie, Sophie, Niedzwiedz, Wojciech, Hoffmann, Jean-Sébastien, Tarsounas, Madalena
Julkaisussa Nat Commun (2017)

Corrigendum: MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells

Tekijä Lai, Xianning, Broderick, Ronan, Bergoglio, Valérie, Zimmer, Jutta, Badie, Sophie, Niedzwiedz, Wojciech, Hoffmann, Jean-Sébastien, Tarsounas, Madalena
Julkaisussa Nat Commun (2017)

Putting the BRK on breast cancer: From molecular target to therapeutics

Tekijä Ang, Hui Li, Yuan, Yi, Lai, Xianning, Tan, Tuan Zea, Wang, Lingzhi, Huang, Benjamin BoJun, Pandey, Vijay, Huang, Ruby Yun-Ju, Lobie, Peter E., Goh, Boon Cher, Sethi, Gautam, Yap, Celestial T., Chan, Ching Wan, Lee, Soo Chin, Kumar, Alan Prem
Julkaisussa Theranostics (2021)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity

Tekijä Tacconi, Eliana MC, Lai, Xianning, Folio, Cecilia, Porru, Manuela, Zonderland, Gijs, Badie, Sophie, Michl, Johanna, Sechi, Irene, Rogier, Mélanie, Matía García, Verónica, Batra, Ankita Sati, Rueda, Oscar M, Bouwman, Peter, Jonkers, Jos, Ryan, Anderson, Reina‐San‐Martin, Bernardo, Hui, Joannie, Tang, Nelson, Bruna, Alejandra, Biroccio, Annamaria, Tarsounas, Madalena
Julkaisussa EMBO Mol Med (2017)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance

Tekijä Tacconi, Eliana MC, Badie, Sophie, De Gregoriis, Giuliana, Reisländer, Timo, Lai, Xianning, Porru, Manuela, Folio, Cecilia, Moore, John, Kopp, Arnaud, Baguña Torres, Júlia, Sneddon, Deborah, Green, Marcus, Dedic, Simon, Lee, Jonathan W, Batra, Ankita Sati, Rueda, Oscar M, Bruna, Alejandra, Leonetti, Carlo, Caldas, Carlos, Cornelissen, Bart, Brino, Laurent, Ryan, Anderson, Biroccio, Annamaria, Tarsounas, Madalena
Julkaisussa EMBO Mol Med (2019)